Diagnostic and therapeutic management of superior vena cava syndrome;Diagnostisches und therapeutisches management der oberen einflussstauung

Medizinische Klinik

Volumn 94, Issue 12, 1999, Pages 681-684

  Dempke, Wolfram ^b   Behrmann, Curt ^b   Schöber, Christoph ^b   Büchele, Thomas ^b   Grothey, Axel ^b   Schmoll, Hans Joachim ^a  

^a Klin Inn Med IV (Hamatologie/O   (Germany)

^b NONE

Author keywords

Diagnostic procedures; Therapeutic management; Vena cava superior syndrome

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; SUPERIOR CAVA VEIN SYNDROME; SURGICAL APPROACH;

EID: 0033572939     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044758     Document Type: Article

References (18)

1. Ahmann FR. A reassessment of the clinical implications of the superior vena cava syndrome. J Clin Oncol 1984;2:961-9.
2. Armstrong BA, Perez CA, Simpson JR, et al. Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 1987;13:531-8.
3. Beattie CW, Hansen NW, Thomas PA. Steroid receptors in human lung cancer. Cancer 1985;45:4206-14.
4. Bell DR, Woods RL, Levi JA. Superior vena caval obstruction: a 10-year experience. Med J Aust 1986; 145:566-602.
5. Bigsby R, Greengrass R, Unruh H. Diagnostic algorithm for acute superior vena cava obstruction. J Cardiovasc Surg 1993;34:347-50.
6. Comerota AJ. Safety and efficacy of thrombolytic therapy for superior vena caval syndrome. Chest 1991;99:3-8.
7. Gray BH, Olin JW, Grador R.A. et al. Safety and efficacy of thromholytic therapy tor superior vena cava syndrome. Chest 1991;99:54-9.
8. Hansen ME, Spritzer CE, Sostman HD. Assessing the patency of mediastinal and thoracic inlet veins: value of MR imaging. Am J Radiol 1990;155:1177-82.
9. Kretschmer S, Schneider W. Obere Einflußstauung als onkologischer Notfall. Dtsch Med Wochenschr 1992;117:1650-5.
10. Lokich JJ, Goodman R. Superior vena cava syndrome: clinical management. JAMA 1975;231:58-66.
11. Nicholson AA, Ettles DF, Arnold A, et al. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Intervent Radiol 1997;8:781-8.
12. Nieto AF, Doty DB. Superior vena cava obstruction: clinical syndrome, etiology and treatment. Curr Probl Cancer 1986;111:442-9.
13. Roswit B, Kaplan G, Jacobson HG. The superior vena cava syndrome in bronchogenic carcinoma. Radiology 1953;61:722-6.
14. Schraufnagel DE, Hill R, Leech JA, et al. Superior vena caval obstruction: is it an emergency? Am J Med 1981;70:1169-73.
15. Shah R, Sabanathan S, Lowe RA, et al. Stenting in malignant obstruction of superior vena cava. J Thorac Cardiovasc Surg 1996;112:335-40.
16. Tanigawa N, Sawada S, Mishima K, et al. Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors. Comparison with conventional treatment Acta Radiol 1998;39:669-74.
17. Yellin A, Mandel M, Rechavi G, et al. Superior vena cava syndrome associated with lymphoma. Am J Dis Child 1992;146:1060-5.
18. Yellin A. Rosen A, Reichert N, et al. Superior vena cava syndrome: the myth - the facts. Am Rev Respir Dis 1990;141:1114-9.